Loading
Choices like mastectomy versus lumpectomy, or whether to have chemotherapy after surgery, depend on what matters to the patient. Good decision aids exist but are rarely used; building them into the clinic workflow would change that.
Decision aids improve knowledge, reduce decisional conflict, and often shift choices toward less intensive treatment in randomised trials, yet routine use is rare. Embedding validated aids into the electronic record so that they are triggered at the relevant decision point, pre-populated with the patient's own risk estimates, and documented as part of consent would make shared decision-making the default rather than an add-on.
One bottleneck page and 18 idea pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
The current shape of the screening question in the United States, and the best short statement of the trade-off in numbers a man can weigh. The three-to-one ratio between metastatic cases prevented and deaths prevented is also the argument for using metastatic presentation, not mortality, to judge a screening programme sooner.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Patients lack understanding, navigation and agency, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Patients lack understanding, navigation and agency, HR-positive / HER2-negative breast cancer, Prostate cancer.
Shares Patients lack understanding, navigation and agency, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.